On the morning of Thursday, April 23, 2020, NIA announced OPKO Health (OPK) at $2.08 per share as its #1 Covid-19 testing stock suggestion. OPK is the owner of BioReference Laboratories one of the largest full-service clinical diagnostics laboratories in the U.S.
Yesterday, OPK exploded by $0.23 or 10.80% to close at its high of day of $2.36 per share! OPK has so far gained by 13.46% from NIA's April 23rd suggestion price of $2.08 per share!
NIA continues to believe on a conservative basis that OPK will rise to $3 per share in the upcoming weeks. When OPK first announced on March 5, 2020 that BioReference Laboratories would begin rolling out Covid-19 testing, it made an explosive two-day gain of 75.3% to a March 6, 2020 intraday high of $2.91 per share, before closing March 6th at $2.32 per share on enormous volume of 103.868 million shares.
OPK has finally closed above its March 6th closing price of $2.32 per share and it made yesterday's HUGE breakout on relatively low volume of only 10.865 million shares, which means OPK's resistance is gone and the shorts are beginning to get squeezed!
Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. Never make investment decisions based on anything NIA says. This message is meant for informational and educational purposes only and does not provide investment advice.
Preparing Americans for Hyperinflation
